COVID-19: Impact on Vaccines Market Revenue Analyzed and Forecast Growth

Rising incidence of infectious diseases is driving the market for vaccines over the forecast period.

According to The Insight Partners market research study titled 'Vaccines Market - Global Analysis and Forecasts by Technology, Disease Indication, Route of Administration, and Patient Type. The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 36,998.8 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The report highlights the trends prevalent in the global vaccines market and the factors driving the market along with those that act as deterrents to its growth.

Get sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003424/?Source=Openpr-10293

The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2018, the conjugate vaccines segment held a largest market share of 65.1% of the vaccines market, By Technology. This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.

Driving factors such as, growing focus on immunization programs, increasing support for vaccine development, rising prevalence of infectious diseases. However, the complexity and cost of vaccine manufacturing and soaring costs of vaccines are likely to pose a negative impact on the market growth. On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years.

Some of the prominent players operating in vaccines market are PFIZER INC, GlaxoSmithKline plc, Merck & Co., Inc., Sanofi, Johnson & Johnson Services, Inc, Panacea Biotec Limited, Astellas Pharma Inc., NOVAVAX, INC., VBI Vaccines Inc, and Bavarian Nordic. The market players are focused towards bringing new and innovative products and services to sustain their position in the market.

For instance, in December, 2018, The European Commission has granted marketing authorization for Dengvaxia, Sanofi's dengue vaccine. The marketing authorization follows the October 18, 2018, recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) to approve use of the dengue vaccine in European endemic areas. The developments performed by the companies are helping the market to grow in the coming years.

Buy Now This Report @ https://www.theinsightpartners.com/buy/TIPRE00003424/?Source=Openpr-10293

The report segments the global vaccines market as follows:

Global Vaccines Market - By Technology

Recombinant vaccines
Conjugate Vaccines
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines

Global Vaccines Market - By Disease Indication

DTP (diphtheria, tetanus, and pertussis)
Influenza
Hepatitis
Respiratory Syncytial Virus (RSV)
Other Diseases

Global Vaccines Market - By Route of Administration

Oral
Injectable
Other

Global Vaccines Market - By Patient Type

Adult Patients
Pediatric Patients

Contact Us:
Call: +1-646-491-9876
Email:sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.